BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18339134)

  • 1. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
    Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
    Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
    Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
    J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney.
    Kabat-Koperska J; Baśkiewicz-Masiuk M; Safranow K; Gołembiewska E; Paczkowska E; Mikłaszewicz A; Kedzierska K; Giedrys-Kalemba S; Machaliński B; Ciechanowski K
    Transplant Proc; 2005 Mar; 37(2):755-9. PubMed ID: 15848522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation.
    Kujawa-Szewieczek A; Kolonko A; Kocierz M; Szotowska M; Trusolt W; Karkoszka H; Gumprecht J; Chudek J; Więcek A
    Transplant Proc; 2011 Oct; 43(8):2957-63. PubMed ID: 21996200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of gene polymorphism of the angiotensin-converting enzyme in donor and recipient on the function of renal graft].
    Kabat-Koperska J
    Ann Acad Med Stetin; 2005; 51(1):107-15. PubMed ID: 16496610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme genotype is a predictive factor in the peak panel-reactive antibody response.
    Akçay A; Ozdemir FN; Ataç FB; Sezer S; Verdi H; Arat Z; Haberal M
    Transplant Proc; 2004; 36(1):35-7. PubMed ID: 15013293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
    Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
    Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients.
    du Cheyron D; Fradin S; Ramakers M; Terzi N; Guillotin D; Bouchet B; Daubin C; Charbonneau P
    Crit Care Med; 2008 Dec; 36(12):3178-83. PubMed ID: 19020433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
    Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis.
    Micozkadioğlu H; Colak T; Akçay A; Sezer S; Ataç FB; Verdi H; Arat Z; Ozemir FN; Haberal M
    Transplant Proc; 2004; 36(1):161-3. PubMed ID: 15013333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
    Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
    Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
    Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
    Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
    Savin M; Petronić V
    Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.